PAN-Biotech
Private Company
Funding information not available
Overview
PAN-Biotech is a well-established, privately-held German company providing essential tools and services for the biotechnology and pharmaceutical industries. With over 35 years of experience, it has built a strong reputation for high-quality, 'Made in Germany' cell culture media and reagents, with a strategic focus on enabling next-generation therapies. The company operates both as a product supplier and a contract service provider through its Quality-Test & Research Center, positioning itself as a critical enabler in the rapidly growing fields of advanced therapeutics and biologics manufacturing.
Technology Platform
Advanced cell culture media formulation and serum-free technology, with specialized expertise for cell/gene therapy, mRNA production, and antibody manufacturing. Complementary analytical testing services for quality control.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
PAN-Biotech competes in the global cell culture media and bioprocessing reagents market, which is dominated by giants like Thermo Fisher Scientific, Merck KGaA, and Sartorius. Its competitive strategy relies on specialization, deep technical expertise in serum-free formulation, a high-quality 'Made in Germany' brand, and a customer-partnership model, rather than competing on scale alone.